Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 5, 2009, Pages 872-874

  Cassidy, Frederick ^a,b   Weiner, Richard D ^a,c   Cooper, Thomas B ^d   Carroll, Bernard J ^a,e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b John Umstead Hospital   (United States)

^c Veteran's Administration Hospital   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e Pacific Behavioral Research Foundation   (United States)

Author keywords

Catecholamine; Dopamine; ECT; Mechanism depression; Norepinephrin

Indexed keywords

3 METHOXY 4 HYDROXYENYLETHYLENEGLYCOL; CATECHOLAMINE; ETHYLENE GLYCOL; HOMOVANILLIC ACID; METIROSINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CATECHOLAMINE DEPLETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NORADRENERGIC SYSTEM; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; CATECHOLAMINES; COHORT STUDIES; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 67649233096     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.04.005     Document Type: Article

References (16)

1. Alfredsson G., Wiesel F.A., and Tylec A. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 23 (1988) 689-697
2. Cassidy F., Murry E., Weiner R.D., and Carroll B.J. Lack of relapse with tryptophan depletion following successful treatment with ECT. Am J Psychiatry 154 (1997) 1151-1152
3. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., and Heninger G. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47 (1990) 411-418
4. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Heninger G.R., Gelenberg A.J., et al. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29 (1993) 389-396
5. Fleiss J. The design and analysis of clinical experiments (1986), John Wiley, New York
6. Fochtmann L.J. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 30 (1994) 321-444
7. Fri C.G., Wiesel F.A., and Sedvall G. Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. Life Sci 14 (1974) 2469-2480
8. Gobert A.R.J., Audinot V., Newman-Tancredi A., Cistarelli L., and Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84 (1998) 413-429
9. Kellner C.H., Knapp R.G., Petrides G., Rummans T.A., Husain M.M., Rasmussen K., et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63 (2006) 1337-1344
10. Mann J.J. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J Ect 14 (1998) 172-180
11. Miller H.L., Delgado P.L., Salomon R.M., Berman R., Krystal J.H., Heninger G.R., et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 53 (1996) 117-128
12. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
13. Newman M.E., Gur E., Shapira B., and Lerer B. Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J Ect 14 (1998) 153-171
14. Sackeim H.A., Haskett R.F., Mulsant B.H., Thase M.E., Mann J.J., Pettinati H.M., et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. J Am Med Assoc 285 (2001) 1299-1307
15. van den Broek W.W., Birkenhager T.K., Mulder P.G., Bruijn J.A., and Moleman P. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67 (2006) 263-268
16. Wahlund B., and von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology 28 Suppl 1 (2003) S21-S26